Effect of isoniazid, a haem inhibitor, on globin chain synthesis in reticulocytes from non-thalassaemic and beta thalassaemic subjects
- PMID: 2794087
- PMCID: PMC501799
- DOI: 10.1136/jcp.42.9.977
Effect of isoniazid, a haem inhibitor, on globin chain synthesis in reticulocytes from non-thalassaemic and beta thalassaemic subjects
Abstract
The effect of isonicotinic acid hydrazide (INH), a potent haem inhibitor, on globin chain synthesis was studied in reticulocytes from the following groups of patients: four non-thalassaemic patients (group i); five beta thalassaemia heterozygotes (group ii); three Hb S/beta thalassaemia heterozygotes (group iii); and two additional patients--one with homozygous beta thalassaemia and the other with thalassaemia intermedia (group iv). This was done to determine whether haem inhibitors depress alpha globin chain synthesis. The progressive increase of INH concentration (10-40 mmol l-1) in reticulocytes from a beta thalassaemia heterozygote resulted in a remarkable decrease of the alpha and beta chain synthesis, ranging from 80% to 97% and from 74% to 96% of control values, respectively, and in a gradual drop of alpha:beta ratio from 1.87 to 1.38. Furthermore, in the samples incubated with 40 mmol l-1 INH, a pronounced inhibition of globin chain synthesis 77 (19%) for alpha chain and 67 (27%) for beta or beta S chain) and a substantial drop of the alpha:beta or beta S ratio in samples with INH (median 1.16) compared with that in samples without INH (median 1.70) were observed. The inhibitory effect of INH was significantly or completely corrected by adding exogenous haem. It is suggested that haem inhibition and the resulting preferential diminution of alpha chain synthesis could provide a new approach to the treatment of homozygous beta thalassaemia with an excess of detrimental free alpha chain in erythroid cells.
Similar articles
-
Globin chain synthesis ratios in sideroblastic anaemia.Br J Haematol. 1983 Feb;53(2):201-9. doi: 10.1111/j.1365-2141.1983.tb02012.x. Br J Haematol. 1983. PMID: 6821649
-
Globin chain synthesis in sickle beta-thalassaemic bone marrow and reticulocytes.J Med Genet. 1979 Aug;16(4):296-301. doi: 10.1136/jmg.16.4.296. J Med Genet. 1979. PMID: 490583 Free PMC article.
-
Bone marrow and peripheral blood globin chain synthesis in sickle cell beta zero thalassaemia.J Med Genet. 1986 Jun;23(3):252-5. doi: 10.1136/jmg.23.3.252. J Med Genet. 1986. PMID: 3723554 Free PMC article.
-
Interaction between iron deficiency and alpha-thalassaemia: the in vitro effect of haemin on alpha-chain synthesis.Acta Haematol. 1978;60(1):1-9. doi: 10.1159/000207689. Acta Haematol. 1978. PMID: 97895
-
Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene.Front Genome Ed. 2021 Sep 30;3:752278. doi: 10.3389/fgeed.2021.752278. eCollection 2021. Front Genome Ed. 2021. PMID: 34713267 Free PMC article. Review.
Cited by
-
Severe isoniazid related sideroblastic anemia.Hematol Rep. 2011 Jan 13;3(1):e2. doi: 10.4081/hr.2011.e2. Epub 2011 Jan 21. Hematol Rep. 2011. PMID: 22184524 Free PMC article.
-
Emodin can induce K562 cells to erythroid differentiation and improve the expression of globin genes.Mol Cell Biochem. 2013 Oct;382(1-2):127-36. doi: 10.1007/s11010-013-1726-3. Epub 2013 Jun 7. Mol Cell Biochem. 2013. PMID: 23744534
-
Globin chain synthesis in myelodysplastic syndromes.J Clin Pathol. 1991 Feb;44(2):134-8. doi: 10.1136/jcp.44.2.134. J Clin Pathol. 1991. PMID: 1864985 Free PMC article.
-
Sideroblastic anemia Secondary to anti-tubercular Therapy in a Patient with Acute Promyelocytic Leukemia.Indian J Hematol Blood Transfus. 2025 Apr;41(2):447-448. doi: 10.1007/s12288-024-01824-9. Epub 2024 Jul 30. Indian J Hematol Blood Transfus. 2025. PMID: 40224705 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical